We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

LLY’s slashed revenue and earnings guidance for 2024 were a surprise, especially given substantial raises to its outlook ...

On Tuesday, Eli Lilly And Co (LLY) stock saw a modest uptick, ending the day at $903.58 which represents a slight increase of $7.99 or 0.89% from the prior close of $895.59. The stock opened at ...

Type 2 diabetes drug Mounjaro and weight-loss drug Zepbound remained the brightest stars in Lilly's lineup. Mounjaro's sales ...

The company reported revenue of $11.4 billion and adjusted earnings of $1.18 per share, well below the consensus estimates of $12.1 billion and $1.45, respectively.

Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) were down 0.7% during mid-day trading on Friday after Barclays lowered their price target on the stock from $1,025.00 to $975.00. Barclays ...

Eli Lilly's stock valuation sank by $100 billion Wednesday morning after the pharma giant reported third quarter earnings.

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

Eli Lilly and Company disappointed with missed earnings, lower guidance. Click here for my review of LLY Q3 earnings and a ...

Eli Lilly and Company (NYSE:LLY – Get Free Report)’s share price traded up 0.6% during trading on Friday after Citigroup raised their price target on the stock from $1,060.00 to $1,250.00. Citigroup ...

Moving ahead, Rob Rowe, Regional Research Director and Head of Global Strategy at a large US bank is ‘ tactically bullish ’ on the back of continuing tech recovery and the markets “pricing in a soft ...

As if there weren't enough reasons to buy shares of the cardiometabolic drug juggernauts Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), there's now one more big reason to expect these two stocks ...